Kuros Biosciences AG
SIX:KURN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kuros Biosciences AG
SIX:KURN
|
CH |
|
L
|
Lithium Royalty Corp
TSX:LIRC
|
CA |
|
N
|
Northam Platinum Holdings Ltd
JSE:NPH
|
ZA |
|
O
|
OMS Energy Technologies Inc
NASDAQ:OMSE
|
SG |
|
Central Security Patrols Co Ltd
TSE:9740
|
JP |
|
A
|
American Express Co
XMUN:AEC1
|
US |
|
Faurecia SE
OTC:FURCF
|
FR |
Wall St Price Targets
KURN Price Targets Summary
Kuros Biosciences AG
According to Wall Street analysts, the average 1-year price target for KURN is 38.76 CHF with a low forecast of 38.38 CHF and a high forecast of 39.9 CHF.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KURN's stock price target?
Price Target
38.76
CHF
According to Wall Street analysts, the average 1-year price target for KURN is 38.76 CHF with a low forecast of 38.38 CHF and a high forecast of 39.9 CHF.
What is the Revenue forecast for Kuros Biosciences AG?
Projected CAGR
39%
Over the last 14 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 3 years is 39%.
What is the Operating Income forecast for Kuros Biosciences AG?
Projected CAGR
95%
The compound annual growth rate for Operating Income over the next 3 years is 95%.
What is the Net Income forecast for Kuros Biosciences AG?
Projected CAGR
163%
The compound annual growth rate for Net Income over the next 3 years is 163%.
